SXI Life Sciences
7.543,47
PKT
-11,11
PKT
-0,15
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.12.11 | Tecan (N) hold | Vontobel Research | |
| 01.12.11 | Novartis neutral | Citigroup Corp. | |
| 29.11.11 | Novartis underperform | Cheuvreux SA | |
| 28.11.11 | Novartis hold | Vontobel Research | |
| 25.11.11 | Tecan (N) hold | Vontobel Research | |
| 17.11.11 | Novartis hold | Vontobel Research | |
| 15.11.11 | Sonova buy | Vontobel Research | |
| 03.11.11 | Novartis buy | Deutsche Bank AG | |
| 28.10.11 | Lonza neutral | Citigroup Corp. | |
| 28.10.11 | Novartis neutral | Goldman Sachs Group Inc. | |
| 28.10.11 | Newron PharmaceuticalsAz. hold | Vontobel Research | |
| 28.10.11 | Lonza hold | Vontobel Research | |
| 27.10.11 | Novartis buy | Nomura | |
| 27.10.11 | BB Biotech buy | Close Brothers Seydler Research AG | |
| 27.10.11 | Novartis buy | Citigroup Corp. | |
| 26.10.11 | Novartis outperform | Credit Suisse Group | |
| 26.10.11 | Novartis neutral | Exane-BNP Paribas SA | |
| 26.10.11 | Novartis halten | Independent Research GmbH | |
| 26.10.11 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 25.10.11 | Straumann buy | Nomura | |
| 25.10.11 | Straumann hold | Vontobel Research | |
| 25.10.11 | Sonova buy | Vontobel Research | |
| 25.10.11 | Novartis hold | Vontobel Research | |
| 24.10.11 | Novartis hold | Vontobel Research | |
| 21.10.11 | Straumann sell | Citigroup Corp. | |
| 21.10.11 | BB Biotech kaufen | Independent Research GmbH | |
| 21.10.11 | Newron PharmaceuticalsAz. hold | Vontobel Research | |
| 21.10.11 | Lonza hold | Vontobel Research | |
| 21.10.11 | Straumann hold | Société Générale Group S.A. (SG) | |
| 20.10.11 | Sonova hold | Vontobel Research | |
| 19.10.11 | Novartis outperform | Credit Suisse Group | |
| 19.10.11 | Novartis kaufen | Independent Research GmbH | |
| 19.10.11 | Sonova hold | Vontobel Research | |
| 18.10.11 | Novartis buy | Société Générale Group S.A. (SG) | |
| 17.10.11 | Novartis hold | Vontobel Research | |
| 17.10.11 | Lonza hold | Vontobel Research | |
| 14.10.11 | Straumann hold | Vontobel Research | |
| 11.10.11 | Lonza neutral | Citigroup Corp. | |
| 10.10.11 | Novartis buy | Citigroup Corp. | |
| 07.10.11 | Basilea Pharmaceutica buy | Citigroup Corp. |